Latest Result Updates Of Three AIM listed Stocks: AGY, IMMO, TMMG

  • Sep 25, 2019 BST
  • Team Kalkine
Latest Result Updates Of Three AIM listed Stocks: AGY, IMMO, TMMG
Allergy Therapeutics PLC

Allergy Therapeutics PLC (AGY) is a leader and pioneer in developing immunity-based products for allergy treatments. The company, with its Research & Development team with specialist experience believes in curing the cause instead of diagnosing symptoms. The products of the company are free from Aluminium, convenient to use and can cure the allergies in a shorter span of time. The company aims to transform human lives by breakthrough innovation in treatment for allergy and immune- related disorders. Allergy Therapeutics has a strong foothold in Europe and a strong presence in Germany, Italy, Switzerland, Spain and the United Kingdom. The company also has an indirect presence in markets such as Canada, Slovakia and the Czech Republic. Stronger individual market performances with developments in pipeline help the company in creating value for the stakeholders.

AGY-Financial Highlights for FY19

On 25th September 2019, the company announced its full-year preliminary results for the period ended 30th June 2019. The company’s revenue surged by 8 per cent to £73.7 million in FY19 as against £68.3 million in FY18. The company’s cost of sales surged to £18.4 million in FY19 as against £17.0 million in FY18. The company’s net profit stood at £3.5 million in FY19. The company’s gross margin remained flat in FY19 as compared to the previous year at 75 per cent. The company managed to lower its overheads successfully by £1.1 million to £57.6 million in FY19 as against £58.7 million in FY18. The company invested in new manufacturing capacity to increase automation and replace older equipment this year which resulted in a rise of property, plant & equipment by £1.4 million to £11.5 million in FY19 as against £10.1 million in FY18. Due to a rise in equity, trading and settlement of the legal case (Inflamax), the company managed to generate a net cash inflow of £11.8 million in FY19. The company had cash balances of £27.4 million at 30th June 2019.

AGY-Share price performance

Daily Chart as on 25-September-19, before the market close (Source: Thomson Reuters)

On 25th September 2019, while writing at 12:56 PM GMT, Allergy Therapeutics PLC shares were clocking a current market price of GBX 13.1 per share; which was less by 0.77 per cent in comparison to the last traded price of the previous day. The company’s market capitalisation was at £82.31 million at the time of writing.

On 4th October 2018, the shares of AGY have touched a new peak of GBX 24.50 and reached the lowest price level of GBX 7.30 on 19th March 2019 in the last 52 weeks. The company’s shares were trading at 46.53 per cent lower from the 52-week high price mark and 79.45 per cent higher than the 52-week low price mark at the current trading level as can be seen in the price chart.

The stock’s traded volume was hovering around 121,141 at the time of writing before the market close. The company’s 5-day stock's average traded volume was 82,111.80; 30 days average traded volume- 485,332.40 and 90 days average traded volume – 773,508.96. The beta of the stock was 0.90, making it 10 per cent less volatile in comparison to the market index.

The shares of the company have delivered a negative return of 5.45 per cent in the last quarter. The company’s stock plunged by 4.59 per cent from the start of the year to till date. The company’s stock has given investors 46.94 per cent of a negative return in the last year. 

Immotion Group PLC

British company, Immotion Group plc (IMMO) was established in 2017 by Martin Higginson and David Marks. The company is into the business of developing fully immersive virtual reality (VR) based applications and platforms such as cinema pods and gaming consoles. The VR platforms are equipped for delivering VR content with immersive sound quality and graphics.

IMMO-Financial highlights for H1 FY19

On 25th September 2019, the company announced its interim results for the period ended 30th June 2019. For the first half of the financial year 2019, the revenue of the company was recorded at £1.3 million. The company saw strong trading in summer (July/August) with aggregate revenue being recorded at £0.9 million. The company installed 256 headsets during the period with 33 more installs expected in upcoming weeks. The company was able to raise £2.4 million in gross by the placement of equity shares which completed in July 2019. The company had cash balances of £737 thousand by the end of H1 FY19. The company aims to install around 1000 headsets by the end of 2020.

IMMO-Share price performance

Daily Chart as on 25-September-19, before the market close (Source: Thomson Reuters)

On 25th September 2019, while writing at 01:03 PM GMT, Immotion Group plc shares were clocking a current market price of GBX 6.69 per share; which was less by 0.88 per cent in comparison to the last traded price of the previous day. The company’s market capitalisation was at £19.18 million at the time of writing.

On 28th September 2018, the shares of IMMO have touched a new peak of GBX 12.75 and reached the lowest price level of GBX 4.50 on 01st April 2019 in the last 52 weeks. The company’s shares were trading at 47.52 per cent lower from the 52-week high price mark and 48.66 per cent higher than the 52-week low price mark at the current trading level as can be seen in the price chart.

The stock’s traded volume was hovering around 975,099 at the time of writing before the market close. The company’s 5-day stock's average traded volume was 660,155.80; 30 days average traded volume- 612,858.13 and 90 days average traded volume – 995,076.61. The beta (180 days) of the stock was negatively correlated in comparison to the market index.

The shares of the company have delivered a negative return of 28.19 per cent in the last quarter. The company’s stock plunged by 21.51 per cent from the start of the year to till date. The company’s stock has given investors 47.06 per cent of a negative return in the last year. 

The Mission Group PLC

The Mission Group PLC (TMMG) is a London, United Kingdom-headquartered technology-embraced marketing communications and advertising company which comprise of 16 marketing agencies. The group operates in the United Kingdom, Asia, and the United States and is engaged in delivering digital, brand, marketing, advertising and full-service communications. The group has two divisions: Sector Specialist Agencies, which assists with marketing ideas aimed at highly specialist audiences, and Integrated Agencies, which delivers campaigns across every platform. The operations are differentiated in four operating segments: Advertising & Digital, Media Buying, Exhibitions & Learning and Public Relations. The company was formerly known as Mission Marketing Group PLC.

TMMG-Financial highlights for H1 FY19

On 25th September 2019, the company announced its interim results for the period ended 30th June 2019. The company’s revenue from continuing operations surged by 9 per cent to £39.2 million in H1 FY19 as against £36.1 million in H1 FY18. The company’s profit before taxation surged by 10 per cent to £3.4 million in H1 FY19 as against £3.1 million in H1 FY18. The company’s diluted earnings per share were up by 9 per cent to 3.12 pence in H1 FY19 as against 2.85 pence in H1 FY18. The company’s net debt (bank) stood at £5.1 million by the end of H1 FY19. The company declared a semi-annual dividend of 0.77 pence per share in first half of the financial year 2019, which was 10 per cent more in comparison to the same period the previous year. Registered shareholders as on 1st November 2019 will be eligible for dividend pay-out on 29th November 2019.

TMMG-Share price performance

Daily Chart as on 25-September-19, before the market closed (Source: Thomson Reuters)

On 25th September 2019, while writing at 01:11 PM GMT, The Mission Group PLC shares were clocking a current market price of GBX 80.6 per share. The company’s market capitalisation was at £71.31 million at the time of writing.

On 8th July 2019, the shares of TMMG have touched a new peak of GBX 96 and reached the lowest price level of GBX 49 on 2nd January 2019 in the last 52 weeks.

The stock’s traded volume was hovering around 121,546 at the time of writing before the market close. The company’s 5-day stock's average traded volume was 48,445.80; 30 days average traded volume- 78,778.87 and 90 days average traded volume – 138,103.64. The beta of the stock was 1.04, making it 4 per cent more volatile in comparison to the market index.

The shares of the company have delivered a negative return of 3.45 per cent in the last quarter. The company’s stock surged by 55.56 per cent from the start of the year to till date. The company’s stock has given investors 52.73 per cent of a positive return in the last year.

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK